Mar 23, 2022 In the News

BioGenerator portfolio tops $2.5 billion in follow-on capital for St. Louis bioscience companies

› BioSTL for St. Louis Business Journal

Mar 18, 2022 In the News, KMOX Nothing Impossible

Nothing Impossible: BioGenerator Milestone

› KMOX NewsRadio 1120

Mar 17, 2022 In the News

BioGenerator-backed Wugen, which has raised $200M+ in VC funding, launches clinical trial for cancer drug

› St. Louis Business Journal

Mar 14, 2022 In the News, Video

On TV: President Biden’s Cancer Moonshot is Expected to Fund Innovative Treatments in St. Louis

› HEC-TV

Mar 10, 2022 In the News

The Brookings Institution: St. Louis is a 'Rising Star'

› Brookings Institution

Feb 24, 2022 In the News

2022 Startups to Watch: BioGenerator Companies Make the List

› St. Louis Business Journal

Feb 1, 2022 In the News

BioGenerator backs 18 startups with $3.3M investment, plots 'aggressive' funding strategy for 2022

› St. Louis Business Journal

Jan 20, 2022 In the News

BioGenerator receives grant from Wells Fargo to 'jump start' new agriculture venture

› St. Louis Business Journal

Dec 16, 2021 In the News

Nicklaus: St. Louis is no longer flyover country for venture capitalists. It’s a cover story.

› St. Louis Post-Dispatch